https://doi.org/10.1371/journal.ppat.1003278.g006
H
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
0
Citations
0
h-index
0
i10-index
Hin Chu is an academic researcher from Hong Kong Science and Technology Parks Corporation. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & interferon and immune responses & COVID-19 Clinical Research Studies.
Papers by this author
worksRab14 interaction with FIP1C is required for HIV-1 Env incorporation.
2015 · Figshare · 0 citations
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.12853661.v1
Large-scale sequence analysis reveals novel human-adaptive markers in PB2 segment of seasonal influenza A viruses
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7936946
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.12853661.v2
Author Correction: Identification and characterization of GLDC as host susceptibility gene to severe influenza
2025 · EMBO Molecular Medicine · 0 citations
https://doi.org/10.1038/s44321-024-00164-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat